Cva Family Office, LLC Prothena Corp Public LTD CO Transaction History
Cva Family Office, LLC
- $634 Million
- Q1 2025
A detailed history of Cva Family Office, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Cva Family Office, LLC holds 72 shares of PRTA stock, worth $581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72
Previous 72
-0.0%
Holding current value
$581
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PRTA
# of Institutions
194Shares Held
39.1MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$93.6 Million7.5% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$31.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$29.8 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$18.1 Million0.44% of portfolio
-
State Street Corp Boston, MA1.86MShares$15 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $379M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...